A detailed history of Seven Bridge Financial Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 46,991 shares of BMY stock, worth $2.77 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
46,991
Previous 45,898 2.38%
Holding current value
$2.77 Million
Previous $1.91 Million 27.54%
% of portfolio
0.44%
Previous 0.41%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $43,348 - $56,562
1,093 Added 2.38%
46,991 $2.43 Million
Q2 2024

Aug 09, 2024

SELL
$40.25 - $52.99 $65,446 - $86,161
-1,626 Reduced 3.42%
45,898 $1.91 Million
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $176,326 - $199,920
-3,675 Reduced 7.18%
47,524 $2.58 Million
Q4 2023

Jan 22, 2024

SELL
$48.48 - $57.85 $23,367 - $27,883
-482 Reduced 0.93%
51,199 $2.63 Million
Q3 2023

Oct 25, 2023

BUY
$57.89 - $64.73 $148,719 - $166,291
2,569 Added 5.23%
51,681 $3 Million
Q2 2023

Jul 26, 2023

BUY
$63.71 - $70.74 $50,776 - $56,379
797 Added 1.65%
49,112 $3.14 Million
Q1 2023

Apr 20, 2023

BUY
$65.71 - $74.53 $22,801 - $25,861
347 Added 0.72%
48,315 $3.35 Million
Q4 2022

Jan 26, 2023

BUY
$68.48 - $81.09 $76,492 - $90,577
1,117 Added 2.38%
47,968 $0
Q3 2022

Oct 17, 2022

BUY
$0.13 - $76.84 $1,742 - $1.03 Million
13,404 Added 40.08%
46,851 $3.33 Million
Q2 2022

Jul 12, 2022

SELL
$72.62 - $79.98 $43,644 - $48,067
-601 Reduced 1.77%
33,447 $2.58 Million
Q1 2022

Apr 15, 2022

SELL
$61.48 - $73.72 $325,044 - $389,757
-5,287 Reduced 13.44%
34,048 $2.49 Million
Q4 2021

Jan 20, 2022

BUY
$53.63 - $62.52 $2.11 Million - $2.46 Million
39,335 New
39,335 $2.45 Million
Q4 2021

Jan 20, 2022

SELL
$53.63 - $62.52 $2.12 Million - $2.47 Million
-39,581 Closed
0 $0
Q3 2021

Oct 14, 2021

SELL
$59.17 - $69.31 $8,875 - $10,396
-150 Reduced 0.38%
39,581 $2.34 Million
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $104,442 - $113,737
1,687 Added 4.43%
39,731 $2.66 Million
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $122,952 - $138,285
2,072 Added 5.76%
38,044 $2.4 Million
Q4 2020

Jan 19, 2021

BUY
$57.74 - $65.43 $436,745 - $494,912
7,564 Added 26.63%
35,972 $2.23 Million
Q3 2020

Oct 22, 2020

BUY
$57.43 - $63.64 $472,706 - $523,820
8,231 Added 40.79%
28,408 $1.71 Million
Q2 2020

Jul 24, 2020

BUY
$54.82 - $64.09 $393,114 - $459,589
7,171 Added 55.14%
20,177 $1.19 Million
Q1 2020

Apr 16, 2020

BUY
$46.4 - $67.43 $192,884 - $280,306
4,157 Added 46.98%
13,006 $725,000
Q4 2019

Jan 17, 2020

BUY
$49.21 - $64.19 $50,440 - $65,794
1,025 Added 13.1%
8,849 $568,000
Q3 2019

Oct 09, 2019

SELL
$42.77 - $50.71 $31,820 - $37,728
-744 Reduced 8.68%
7,824 $397,000
Q2 2019

Jul 15, 2019

BUY
$44.62 - $49.34 $30,698 - $33,945
688 Added 8.73%
8,568 $389,000
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $21,071 - $25,124
467 Added 6.3%
7,880 $376,000
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $82,648 - $107,174
-1,695 Reduced 18.61%
7,413 $385,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $10,596 - $11,952
192 Added 2.15%
9,108 $565,000
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $17,685 - $22,043
-350 Reduced 3.78%
8,916 $493,000
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $14,560 - $16,762
-243 Reduced 2.56%
9,266 $586,000
Q4 2017

Feb 20, 2018

BUY
$59.94 - $65.35 $4,015 - $4,378
67 Added 0.71%
9,509 $583,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $41,422 - $47,805
750 Added 8.63%
9,442 $602,000
Q2 2017

Aug 14, 2017

BUY
N/A
8,692
8,692 $484,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Seven Bridge Financial Group, LLC Portfolio

Follow Seven Bridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.